Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

88
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
88
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

57
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
57
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

112
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
112
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Learning from sanctioned government suppliers: a machine learning and network science approach to detecting fraud and corruption in Mexico.

Scientific reports·2026
Same author

Correction: Predicting pharmaceutical prices. Advances based on purchase-level data and machine learning.

BMC public health·2024
Same author

Global Contract-level Public Procurement Dataset.

Data in brief·2024
Same author

Collusion risk in corporate networks.

Scientific reports·2024
Same author

Development aid contracts database: World Bank, Inter-American Development Bank, and EuropeAid.

Data in brief·2022
Same author

The gendered effects of foreign investment and prolonged state ownership on mortality in Hungary: an indirect demographic, retrospective cohort study.

The Lancet. Global health·2017

相关实验视频

Updated: Jun 21, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

预测制药价格. 预测制药价格. 预测制药价格. 预测制药价格. 基于购买级数据和机器学习的进展.

Mihály Fazekas1, Zdravko Veljanov2, Alexandre Borges de Oliveira3

  • 1Department of Public Policy, Central European University, Quellenstraße 51, 1100, Vienna, Austria. fazekasm@ceu.edu.

BMC public health
|July 15, 2024
PubMed
概括
此摘要是机器生成的。

公共卫生预算面临着降低药品成本的压力. 机器学习模型有效地使用购买数据预测药品价格,识别更好的价值的政策干预措施.

关键词:
卫生政策 卫生政策机器学习是机器学习.制药产品 制药产品 制药产品公共采购部门的采购

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

相关实验视频

Last Updated: Jun 21, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.5K

科学领域:

  • 卫生经济学 卫生经济学
  • 制药采购 制药采购 制药采购
  • 在医疗保健中的数据科学.

背景情况:

  • 随着医疗保健成本的上升,药品采购的公共预算受到压力.
  • 国家当局寻求战略,以最低的成本采购高质量的药品.
  • 之前的研究往往忽略了来自公共买家的个人购买数据.

研究的目的:

  • 通过公开的公共采购数据,研究药品单位价格和各种预测指标之间的关系.
  • 确定最有效的模型来预测制药单位价格.
  • 为数据驱动的政策干预提供信息,以提高制药采购的价值与成本.

主要方法:

  • 利用了来自10个国家的超过20万份药品购买记录.
  • 分析了800多个标准化制药产品类别的数据.
  • 采用传统的线性回归 (普通最小平方) 和随机森林机器学习模型.

主要成果:

  • 标准化药品的价格在国家内部和国家之间存在显著的价格差异.
  • 随机森林模型表现出更高的解释差异 (R2=0.85) 和更低的预测误差 (RMSE=0.81) 的优异性能.
  • 线性回归和随机森林模型都显示出预测单位价格的潜力.

结论:

  • 医疗保健中的大规模采购级数据,结合机器学习,可以有效地解释和预测药品价格.
  • 数据驱动的洞察力可以指导政策干预,以提高采购效率和价值.
  • 该研究强调了利用开放采购数据优化药品支出的潜力.